dc.creatorLopera Restrepo, Francisco Javier
dc.creatorJorge Iván, Vélez Valbuena
dc.creatorHardip, Patel
dc.creatorAngad, Johar
dc.creatorCai, Yeping
dc.creatorRivera D., Dora
dc.creatorTobón Quintero, Carlos Andrés
dc.creatorVillegas, Andrés
dc.creatorSepúlveda Falla, Diego
dc.creatorLehmann, Shaun
dc.creatorEasteal, Simon
dc.creatorMastronardi, Claudio
dc.creatorArcos Burgos, Oscar Mauricio
dc.date2023-05-31T18:56:26Z
dc.date2023-05-31T18:56:26Z
dc.date2016
dc.date.accessioned2024-04-23T17:49:59Z
dc.date.available2024-04-23T17:49:59Z
dc.identifier1552-4841
dc.identifierhttps://hdl.handle.net/10495/35187
dc.identifier10.1002/ajmg.b.32493
dc.identifier1552-485X
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9229955
dc.descriptionABSTRACT: The identification of mutations modifying the age of onset (AOO) in Alzheimer’s disease (AD) is crucial for understanding the natural history of AD and, therefore, for early interventions. Patients with sporadic AD (sAD) from a genetic isolate in the extremes of the AOO distribution were whole-exome genotyped. Single- and multi-locus linear mixed-effects models were used to identify functional variants modifying AOO. A posteriori enrichment and bioinformatic analyses were applied to evaluate the non-random clustering of the associate variants to physiopathological pathways involved in AD. We identified more than 20 pathogenic, genome-wide statistically significant mutations of major modifier effect on the AOO. These variants are harbored in genes implicated in neuron apoptosis, neurogenesis, inflammatory processes linked to AD, ligodendrocyte differentiation, and memory processes. This set of new genes harboring these mutations could be of importance for prediction, follow-up and eventually as therapeutical targets of AD.
dc.descriptionCOL0010744
dc.format15
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.languageeng
dc.publisherWiley-Blackwell
dc.publisherGrupo de Neurociencias de Antioquia
dc.publisherHoboken, Estados Unidos
dc.relationAm. J. Med. Genet. B. Neuropsychiatr. Genet.
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectEnfermedad de Alzheimer
dc.subjectAlzheimer Disease
dc.subjectFenotipo
dc.subjectPhenotype
dc.subjectMutación
dc.subjectMutation
dc.subjectGenotipo
dc.subjectGenotype
dc.subjectExoma
dc.subjectExome
dc.subjectGenes Modificadores
dc.subjectGenes, Modifier
dc.titleMutations modifying sporadic Alzheimer's disease age of onset
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typehttp://purl.org/coar/resource_type/c_2df8fbb1
dc.typehttps://purl.org/redcol/resource_type/ART
dc.typeArtículo de periódico


Este ítem pertenece a la siguiente institución